Journals / Turkish Journal of Pharmaceutical Sciences / 2022 / Cilt: 19 - Sayı: 1

Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin

Saksagliptinin Spektrofotometrik Tahmininde Tepki Yüzey Metodolojisi, MBTH ve Ninhidrin ile Türevlendirme

Pages
9–18
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Design of experiments assisted spectrophotometric methods have been established for the quantification of saxagliptin in pharmaceutical formulation via charge transfer complexation and Schiff’s base formation.
📊
Key Findings & Data:Materials and Methods: Box-Behnken design was exploited in method-1, involved the measurement of absorbance of green/blue-colored complex (at 600 nm), formed by the reaction of saxagliptin with 3-methyl-2-benzothiazolinone hydrazone in the presence of ferric chloride.
💡
Conclusion & Impact:Conclusion: The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms
🔬Design:Modeling & Simulation
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Design of experiments assisted spectrophotometric methods have been established for the quantification of saxagliptin in pharmaceutical formulation via charge transfer complexation and Schiff’s base formation. Materials and Methods: Box-Behnken design was exploited in method-1, involved the measurement of absorbance of green/blue-colored complex (at 600 nm), formed by the reaction of saxagliptin with 3-methyl-2-benzothiazolinone hydrazone in the presence of ferric chloride. The central composite design was employed in method-2, involved the determination of absorbance of Ruhemann’s purple (at 585 nm), formed by the reaction of the primary amine group of saxagliptin with ninhydrin reagent in presence of sodium hydroxide. Optimization of reaction variables namely, reagent concentration (A), oxidizing agent/alkalinity (B) and reaction/heat time (C) was performed through response surface methodology for the response (Y) i.e. absorbance of colored compound. The reliability of both methods was investigated through validation as per International Council for Harmonisation guidelines. Results: Saxagliptin executed linearity in the concentration range of 0.01-0.25 μg/mL and 1-10 μg/mL by method-1 and 2. A high value of molar absorptivity, low values of Sandell’s sensitivity and limit of detection/limit of quantification divulges the good sensitivity methods. The % assay of saxagliptin in the marketed formulation was found to be 100.27 and 99.86 by method-1 and method-2, respectively. Conclusion: The proposed eco-friendly and economical methods can be routinely employed in quality control for the analysis of saxagliptin in the pharmaceutical dosage forms

Özet

Amaç: Farmasötik formülasyonlarda saksagliptin miktarının yük transfer kompleksasyonu ve Schiff bazı oluşumu yolları ile belirlenmesi için spektrofotometrik yöntem destekli deney tasarımı oluşturulmuştur. Gereç ve Yöntemler: Yöntem-1’de, demir klorür varlığında, saksagliptin ile 3-metil-2-benzotiazolinon hidrazonun reaksiyonuyla oluşturulan yeşil/mavi renkli kompleksin (600 nm’de) absorbansının ölçülmesini kapsayan Box-Behnken tasarımı kullanılmıştır. Yöntem-2’de, sodyum hidroksit varlığında, saksagliptinin primer amin grubunun ninhidrin reaktifi ile reaksiyonuyla oluşturulan Ruhemann morunun (585 nm’de) absorbansının belirlenmesini kapsayan merkezi kompozit tasarımı kullanılmıştır. Reaktif konsantrasyonu (A), oksitleyici ajan/alkalinite (B) ve reaksiyon/ısı süresi (C) belirlenen reaksiyon değişkenleridir ve optimizasyon, renkli bileşiğin absorbansı gibi cevaplar (Y) için, tepki yüzeyi metodolojisi yoluyla gerçekleştirilmiştir. Her iki yöntemin güvenilirliği, Uluslararası Harmonizasyon Konseyi yönergelerine göre validasyon yoluyla gerçekleştirilmiştir. Bulgular: Saksagliptinin doğrusallık aralığı metot-1 ve 2 için sırasıyla 0,01-0,25 μg/mL ve 1-10 μg/mL konsantrasyon aralığında uygulanmıştır. Yüksek değerli molar absorptivite, düşük değerli Sandell duyarlılığı ve tayin limiti/teşhis limiti değerleri yöntemlerin duyarlılığını ortaya koymaktadır. Pazarlanan formülasyondaki saksagliptin % miktarı, yöntem-1 ve yöntem-2’ye göre sırasıyla 100,27 ve 99,86 olarak bulunmuştur.Sonuç: Ortaya konulan/önerilen çevre dostu ve ekonomik yöntemler, saksagliptinin farmasötik dozaj formlarındaki analizlerinde rutin olarak uygulanabilir

🔖

Cite This Article

NARAPARAJU, S., GURRALA, S., CVS, S., RAJ, S., ANUMOLU, D. P., NIZAMPET, H. (2022). Response Surface Methodology in Spectrophotometric Estimation of Saxagliptin, Derivatization with MBTH and Ninhydrin. Turkish Journal of Pharmaceutical Sciences, Cilt: 19 - Sayı: 1, 9–18. https://ajindex.com/articles/613576

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (11)

  1. Rosenstock J, Sankoh S, List JF. Glucose-lowering activity of the dipeptidyl peptidase-4 inhibitor saxagliptin in drug-naive patients with type 2 diabetes. Diabetes Obes Metab. 2008;10:376-386
  2. Jadzinsky M, Pfützner A, Paz-Pacheco E, Xu Z, Allen E, Chen R; CV181- 039 Investigators. Saxagliptin given in combination with metformin as initial therapy improves glycaemic control in patients with type 2 diabetes compared with either monotherapy: a randomized controlled trial. Diabetes Obes Metab. 2009;11:611-622
  3. Rosenstock J, Aguilar-Salinas C, Klein E, Nepal S, List J, Chen R; CV181-011 Study Investigators. Effect of saxagliptin monotherapy in treatment-naïve patients with type 2 diabetes. Curr Med Res Opin. 2009;25:2401-2411
  4. Koli SN, Belvotagi AV, Mudke RP, Patil SA. UV spectrophotometric method development and validation for estimation of saxagliptin in API and in pharmaceutical dosage form. Int J Pharm Pharm Res. 2019;14:166-179
  5. Zameeruddin M, Bundel SS, Bharkad VB, Khan HN, Sandip TT. Development and validation of UV spectroscopic method for simultaneous estimation of dapagliflozin and saxagliptin in synthetic mixture. Int J Pharm Anal Res. 2019;8:59-66
  6. Bhadauria RS, Agarwal V. Development and validation of UV spectroscopic method for simultaneous estimation of dapagliflozin and saxagliptin in marketed formulation. J Drug Deliv Ther. 2019;9:1160- 1164
  7. Raveendra BG, Kumar RA, Shaheen SD, Greeshma A, Satyanarayana M, Manikanta RSHT, Syam CPB. A novel stability-indicating method for the simultaneous estimation of saxagliptin and dapagliflozin in rat serum by using UV spectroscopy. Pharm Anal Acta. 2018;9:3
  8. Suthar AS, Prajapati L, Joshi A, Patel J, Kharofiya ML, Sahah SBM. Estimation of saxagliptin hydrochloride and dapagliflozin propendiol monohydrate in combined dosage form. J Innov Appl Pharm Sci. 2018;3:1-7
  9. Sisode PS, Raj HA, Jain VC. Simultaneous determination of saxagliptin hydrochloride and glibenclamide in synthetic mixture using spectrophotometric technique (first order derivative method). Asian J Pharm Anal. 2016;6:77-82
  10. Nyola N, Jeyebalan G. Development and validation of UV-Vis spectroscopy method for simultaneous estimation of saxagliptin hydrochloride and metformin hydrochloride in active pharmaceutical ingredient. J Pharm Edu Res. 2012;3:19-23
  11. Kalaichelvi R, Jayachandran E. Validated spectroscopic method for estimation of saxagliptin in pure and from tablet formulation. Int J Pharm Pharm Sci. 2011;3:179-